Page last updated: 2024-09-03

3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide and guanylyl imidodiphosphate

3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide has been researched along with guanylyl imidodiphosphate in 1 studies

Compound Research Comparison

Studies
(3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide)
Trials
(3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide)
Recent Studies (post-2010)
(3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide)
Studies
(guanylyl imidodiphosphate)
Trials
(guanylyl imidodiphosphate)
Recent Studies (post-2010) (guanylyl imidodiphosphate)
14062,356118

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Johnson, RL; Mishra, RK; Srivastava, LK1

Other Studies

1 other study(ies) available for 3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide and guanylyl imidodiphosphate

ArticleYear
Modulation of high-affinity CNS dopamine D2 receptor by L-pro-L-leu-glycinamide (PLG) analogue 3(R)-(N-L-prolylamino)-2-oxo-1-pyrrolidineacetamide.
    Progress in neuro-psychopharmacology & biological psychiatry, 1990, Volume: 14, Issue:5

    Topics: Animals; Binding, Competitive; Cattle; Cell Membrane; Corpus Striatum; Guanylyl Imidodiphosphate; Kinetics; MSH Release-Inhibiting Hormone; Pyrrolidinones; Receptors, Dopamine; Receptors, Dopamine D2; Spiperone

1990